Venezuela Medical Device Registration Timeline: 3 Stages and 7 Milestones

1. Key takeaways

Medical device registration in Venezuela can be decomposed into 3 stages and 7 milestones. Industry sources place the overall cycle somewhere between 10–18 months (GRZAN practical estimate) and 18–36 months (practical estimates used by some third parties). The spread is not a rounding error: it is a factor of two to three, and it is the number that governs budgeting, inventory planning and distributor negotiations.

The core judgement is this: the bottleneck sits before submission, not inside the review. Three pre-submission steps — qualification of the applicant entity, the certification chain behind the foreign manufacturer, and tariff classification — determine whether a file ever reaches technical review. Once the file is inside review, waiting time is largely outside the applicant’s control. Resources should therefore be concentrated on the pre-submission phase instead of being spent on repeatedly chasing review progress.

A second consequence follows from the first. Because the pre-submission phase is the only segment where effort converts reliably into elapsed time saved, it is also the only segment where internal deadlines and performance targets make sense. Attaching a deadline to a stage controlled by the authority creates the appearance of management without any of its effects, and it distorts the reporting that senior management relies on when deciding whether to enter the market at all.

2. Legal basis

Basis of the figures: the ranges cited in this article — 10–18 months, 18–36 months and the 3–6 month preparation window — have no directly citable Venezuelan official instrument behind them and are therefore labeled practical estimate.

The instruments do different jobs and should not be read as a single procedural code. The circular moves the transactional layer: where a file is filed, in what form, and against which account. The decree allocates administrative competence across legal regimes, which is why classification cannot be treated as a customs afterthought. The tariff decree supplies the classification mechanism itself, and the medicines law supplies the underlying registration obligation and the publication step that converts an approval into something a distributor, a hospital tender or a customs broker can actually rely on.

3. Expert insights

Insight 1: the seven milestones are timed by different clocks, and that is the real difficulty in schedule management.

Reading the table by stage rather than by milestone hides the problem. Three milestones in stage one run on a manufacturer clock, one runs on a two-party clock, and three run on an authority clock. A schedule that assigns a single duration to the whole project will be wrong in both directions at once: it will understate preparation and overstate review.

Insight 2: milestone 4 changed in nature after October 28, 2025. The platform migration turned submission from handing a paper dossier to a SACS counter into transacting on COMEX. Entity qualification documents, user accounts and the mapping between the platform form fields and the dossier sections became new preconditions. The preparatory work for this step is routinely underestimated, because it looks like administration rather than like regulatory work, and because the failure mode is silent — the account exists, the form opens, and the file is rejected later for a mismatch nobody checked.

Insight 3: RFI response speed is the only review variable the applicant can influence. Review duration is not controllable, but response time is. Industry sources consistently list incomplete files and missing documents among the main causes of delay, which supports the conclusion that resources belong in the preparation phase. A file that generates no request for information does not shorten the authority’s queue, but it removes the applicant from the queue a second time, and that second entry is usually longer than the first.

4. Practical recommendations

1. Direct 70% of the project’s time and effort into milestones 1–3. For milestone 5, limit activity to status tracking and fast RFI response; do not staff it as if additional effort could accelerate the outcome.
2. Set internal deadlines for milestones 1–3 and include them in performance assessment. For milestones 5 and 7, set a tracking frequency only, with no date commitment attached.
3. Agree an RFI response deadline in the contract with the authorized representative — 10 working days or less is a reasonable target — together with an explicit allocation of responsibility if that deadline is missed.
4. Express the schedule as a range with a confidence level. Do not commit externally to a specific certificate date; commit instead to the date by which the file will be ready for submission, which is a promise the manufacturer can keep.

5. Verification checklist

• □ The project schedule is broken down by the 7 milestones, with the owner marked against each one
• □ Internal deadlines are set for controllable milestones and tracking frequencies for non-controllable ones
• □ The RFI response deadline is agreed in the contract with the authorized representative
• □ The submission entry point is confirmed as the COMEX platform, effective October 28, 2025
• □ No external commitment uses a specific certificate issuance date

Regulatory information verified as of October 29, 2026.

GRZAN provides registration support in Venezuela for manufacturers, importers and authorized representatives, covering entity qualification, the certification chain, dossier compilation, platform filing and post-approval maintenance. For scope, timelines and document requirements, contact info@grzanglobal.com.